. Author manuscript; available in PMC: 2015 Oct 28.

Published in final edited form as: Am J Gastroenterol. 2014 Apr 15;109(6):867–875. doi: 10.1038/ajg.2014.72

Table 2b. Multivariable analysis of CHB phase associated with non-timely HCC screening.

CHB phase	Odds ratio	95% CI	P value
Inactive carriers vs. immune active patients	2.26	1.4–3.8	0.002
Inactive carriers vs. eAg-negative hepatitis	3.28	2.0–5.4	< 0.0001
Inactive carriers vs. possible eAg-negative hepatitis	1.01	0.6–1.6	0.96
Possible eAg-negative hepatitis vs. immune active patients	2.24	1.2–4.1	0.01
Possible eAg-negative hepatitis vs. e-Ag-negative hepatitis	3.25	1.8–5.9	< 0.0001
Immune active vs. eAg-negative hepatitis	1.45	0.8–2.7	0.25

CHB, chronic hepatitis B; CI, confidence interval; HCC, hepatocellular carcinoma.